| 0 |
HUMAN ANTI-HUMAN ANTIBODY TEST |
4 |
0.1481 |
| 1 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
16 |
0.0476 |
| 2 |
EPILEPSY WITH MYOCLONIC-ATONIC SEIZURES |
1 |
0.0357 |
| 3 |
SHORT STATURE |
8 |
0.0305 |
| 4 |
BODY HEIGHT BELOW NORMAL |
16 |
0.0249 |
| 5 |
BONE DENSITY INCREASED |
8 |
0.0201 |
| 6 |
ANTIBODY TEST POSITIVE |
16 |
0.0096 |
| 7 |
DRUG SPECIFIC ANTIBODY |
12 |
0.0088 |
| 8 |
CHEYNE-STOKES RESPIRATION |
2 |
0.0081 |
| 9 |
JUVENILE IDIOPATHIC ARTHRITIS |
16 |
0.0065 |
| 10 |
JOINT DESTRUCTION |
7 |
0.0045 |
| 11 |
WHEELCHAIR USER |
14 |
0.0031 |
| 12 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
7 |
0.0030 |
| 13 |
POLYARTHRITIS |
16 |
0.0030 |
| 14 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
5 |
0.0017 |
| 15 |
ENDOTRACHEAL INTUBATION COMPLICATION |
1 |
0.0017 |
| 16 |
HYPERMAGNESAEMIA |
1 |
0.0015 |
| 17 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
16 |
0.0014 |
| 18 |
PNEUMONIA ASPIRATION |
33 |
0.0013 |
| 19 |
ADRENAL INSUFFICIENCY |
16 |
0.0013 |
| 20 |
GRIMACING |
1 |
0.0013 |
| 21 |
JOINT EFFUSION |
8 |
0.0012 |
| 22 |
PRURIGO |
1 |
0.0011 |
| 23 |
BONE DENSITY ABNORMAL |
4 |
0.0011 |
| 24 |
EXPIRED DRUG ADMINISTERED |
5 |
0.0010 |
| 25 |
OBESITY |
16 |
0.0010 |
| 26 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 27 |
C-REACTIVE PROTEIN ABNORMAL |
6 |
0.0009 |
| 28 |
ARRHYTHMIA SUPRAVENTRICULAR |
1 |
0.0009 |
| 29 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 30 |
SYNOVITIS |
16 |
0.0009 |
| 31 |
DYSMORPHISM |
2 |
0.0008 |
| 32 |
SINUS ARRHYTHMIA |
1 |
0.0008 |
| 33 |
COMA |
35 |
0.0007 |
| 34 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
12 |
0.0007 |
| 35 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 36 |
SINUS ARREST |
1 |
0.0006 |
| 37 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
0.0006 |
| 38 |
SKULL FRACTURE |
1 |
0.0006 |
| 39 |
QUALITY OF LIFE DECREASED |
8 |
0.0006 |
| 40 |
PUPIL FIXED |
1 |
0.0006 |
| 41 |
HYPOPITUITARISM |
1 |
0.0006 |
| 42 |
IMMUNODEFICIENCY |
8 |
0.0005 |
| 43 |
IMPAIRED QUALITY OF LIFE |
7 |
0.0005 |
| 44 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 45 |
DRUG SPECIFIC ANTIBODY PRESENT |
3 |
0.0005 |
| 46 |
CHOLESTATIC LIVER INJURY |
1 |
0.0004 |
| 47 |
BONE DENSITY DECREASED |
14 |
0.0004 |
| 48 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 49 |
C-REACTIVE PROTEIN INCREASED |
16 |
0.0004 |
| 50 |
UNDERDOSE |
32 |
0.0004 |
| 51 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 52 |
HYPOCALCAEMIA |
8 |
0.0004 |
| 53 |
GASTROOESOPHAGEAL REFLUX DISEASE |
34 |
0.0004 |
| 54 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 55 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 56 |
TRISMUS |
2 |
0.0004 |
| 57 |
AREFLEXIA |
1 |
0.0004 |
| 58 |
JOINT INJURY |
8 |
0.0004 |
| 59 |
SEPTIC SHOCK |
16 |
0.0004 |
| 60 |
CONTRAINDICATED PRODUCT ADMINISTERED |
11 |
0.0004 |
| 61 |
PRESCRIBED UNDERDOSE |
7 |
0.0004 |
| 62 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
16 |
0.0003 |
| 63 |
HYPERCAPNIA |
1 |
0.0003 |
| 64 |
ARTHROPATHY |
15 |
0.0003 |
| 65 |
LIVER FUNCTION TEST ABNORMAL |
7 |
0.0002 |
| 66 |
SHOULDER OPERATION |
1 |
0.0002 |
| 67 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 68 |
ARTHRITIS |
17 |
0.0002 |
| 69 |
THERAPY NON-RESPONDER |
9 |
0.0002 |
| 70 |
MOBILITY DECREASED |
14 |
0.0002 |
| 71 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 72 |
NEUTROPHILIA |
1 |
0.0002 |
| 73 |
HYPOKALAEMIA |
8 |
0.0002 |
| 74 |
SOMNOLENCE |
34 |
0.0002 |
| 75 |
DRUG INTOLERANCE |
16 |
0.0002 |
| 76 |
BLEPHAROSPASM |
1 |
0.0002 |
| 77 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
7 |
0.0002 |
| 78 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 79 |
MENINGITIS |
1 |
0.0001 |
| 80 |
PLEURAL EFFUSION |
8 |
0.0001 |
| 81 |
HYPERTHERMIA |
1 |
0.0001 |
| 82 |
CONCUSSION |
1 |
0.0001 |
| 83 |
PSORIASIS |
16 |
0.0001 |
| 84 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 85 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 86 |
SYRINGE ISSUE |
2 |
0.0001 |
| 87 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 88 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 89 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0001 |
| 90 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 91 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 92 |
DISABILITY |
2 |
0.0001 |
| 93 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 94 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 95 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 96 |
INTENTIONAL PRODUCT USE ISSUE |
7 |
0.0001 |
| 97 |
HIATUS HERNIA |
1 |
0.0001 |
| 98 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 99 |
ULCER |
1 |
0.0001 |
| 100 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 101 |
RHEUMATOID ARTHRITIS |
7 |
0.0001 |
| 102 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 103 |
EOSINOPHILIA |
1 |
0.0001 |
| 104 |
DRUG ERUPTION |
1 |
0.0001 |
| 105 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 106 |
GASTRIC ULCER |
1 |
0.0001 |
| 107 |
HYPOTENSION |
10 |
0.0000 |
| 108 |
PRODUCT USE ISSUE |
9 |
0.0000 |
| 109 |
SKIN CANCER |
1 |
0.0000 |
| 110 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 111 |
PRODUCT USE IN UNAPPROVED INDICATION |
10 |
0.0000 |
| 112 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 113 |
VOMITING |
18 |
0.0000 |
| 114 |
GASTRITIS |
1 |
0.0000 |
| 115 |
OFF LABEL USE |
33 |
0.0000 |
| 116 |
LIMB INJURY |
1 |
0.0000 |
| 117 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 118 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 119 |
NEEDLE ISSUE |
1 |
0.0000 |
| 120 |
TACHYCARDIA |
3 |
0.0000 |
| 121 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 122 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 123 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 124 |
EYE DISORDER |
1 |
0.0000 |
| 125 |
DIZZINESS |
15 |
0.0000 |
| 126 |
PYREXIA |
10 |
0.0000 |
| 127 |
HYPOXIA |
1 |
0.0000 |
| 128 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 129 |
DIARRHOEA |
17 |
0.0000 |
| 130 |
ANGIOEDEMA |
1 |
0.0000 |
| 131 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 132 |
DRUG INEFFECTIVE |
29 |
0.0000 |
| 133 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 134 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 135 |
ARTHRALGIA |
8 |
0.0000 |
| 136 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 137 |
HYPERTENSION |
4 |
0.0000 |
| 138 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 139 |
NAUSEA |
14 |
0.0000 |
| 140 |
CONVULSION |
1 |
0.0000 |
| 141 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 142 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 143 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 144 |
DRY MOUTH |
1 |
0.0000 |
| 145 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 146 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 147 |
BALANCE DISORDER |
1 |
0.0000 |
| 148 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 149 |
MUSCLE SPASMS |
2 |
0.0000 |
| 150 |
CARDIAC DISORDER |
1 |
0.0000 |
| 151 |
DYSPHAGIA |
1 |
0.0000 |
| 152 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 153 |
SYNCOPE |
1 |
0.0000 |
| 154 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 155 |
HYPERHIDROSIS |
1 |
0.0000 |
| 156 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 157 |
VISION BLURRED |
1 |
0.0000 |
| 158 |
DRUG INTERACTION |
1 |
0.0000 |
| 159 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 160 |
URTICARIA |
1 |
0.0000 |
| 161 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 162 |
PAIN |
2 |
0.0000 |
| 163 |
FALL |
1 |
0.0000 |
| 164 |
FATIGUE |
1 |
0.0000 |